.png){kind=icon}
返回
Rhinitis 2020: A practice parameter update
.png){kind=icon}
PRE
AI
DOI：10.1016/j.jaci.2020.07.007.png)
.png){kind=icon}
原文求助.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
This comprehensive practice parameter for allergic rhinitis (AR) and nonallergic rhinitis (NAR) provides updated guidance on diagnosis, assessment, selection of monotherapy and combination pharmacologic options, and allergen immunotherapy for AR. Newer information about local AR is reviewed. Cough is emphasized as a common symptom in both AR and NAR. Food allergy testing is not recommended in the routine evaluation of rhinitis. Intranasal corticosteroids (INCS) remain the preferred monotherapy for persistent AR, but additional studies support the additive benefit of combination treatment with INCS and intranasal antihistamines in both AR and NAR. Either intranasal antihistamines or INCS may be offered as first-line monotherapy for NAR. Montelukast should only be used for AR if there has been an inadequate response or intolerance to alternative therapies. Depot parenteral corticosteroids are not recommended for treatment of AR due to potential risks. While intranasal decongestants generally should be limited to short-term use to prevent rebound congestion, in limited circumstances, patients receiving regimens that include an INCS may be offered, in addition, an intranasal decongestant for up to 4 weeks. Neither acupuncture nor herbal products have adequate studies to support their use for AR. Oral decongestants should be avoided during the first trimester of pregnancy. Recommendations for use of subcutaneous and sublingual tablet allergen immunotherapy in AR are provided. Algorithms based on a combination of evidence and expert opinion are provided to guide in the selection of pharmacologic options for intermittent and persistent AR and NAR.
Keyword:
Allergic rhinitis
nonallergic rhinitis
vasomotor rhinitis
local allergic rhinitis
food allergy antihistamines
corticosteroids
ipratropium
allergen immunotherapy
decongestants
AI总结
对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
11.2
论文数:
3.7W
被引数:
5.6W
机构
查看更多机构
引用论文
Versatility of hydrogel-forming microneedles in in vitro transdermal delivery of tuberculosis drugs
PREAI
分享收藏A pathogenic triad in chronic cough -: Asthma, postnasal drip syndrome, and gastroesophageal reflux disease.png)
CHEST
CHESTIF8.6
PREAI
分享收藏
分享收藏
查看更多内容